$7.940
-0.128 (-1.61%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Averages Convergence Divergence (MACD) indicator is -0.25, suggesting BCRX is Strong sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 20-Day simple moving average is 8.19, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $—, making it Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 60-Day simple moving average is 8.96, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $—, making it Sell.
Technical Analysis for BCRX
AI Technical BCRXAs of 2026-10-17, the technical board for BioCryst Pharmaceuticals, Inc. (BCRX) reads strong sell: 2 indicators are flashing buy, 8 are indicating sell, and 3 are neutral. Price at $7.94 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 37.765, MACD stands at -0.249 (Sell), Stochastic %K stands at 22.417, Stochastic %D stands at 22.17 and CCI stands at -121.017 (Buy).
BCRX trades below the 60-day SMA (8.96) and below the 200-day SMA (8.72). Immediate resistance sits at Classic R1 8.54, then R2 9.00. Support sits at Classic S1 7.69, then S2 7.29.
BioCryst Pharmaceuticals, Inc. (BCRX) Support & Resistance Level
BioCryst Pharmaceuticals, Inc. (BCRX) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 37.765 |
| STOCHk_14_3_3 | 22.417 |
| STOCHd_14_3_3 | 22.170 |
| CCI_20 | -121.017 |
| AO_5_34 | -0.477 |
| MOM_10 | -0.615 |
| MACD_12_26_9 | -0.249 |
BioCryst Pharmaceuticals, Inc. (BCRX) Relative Strength Index (RSI_14) is 37.765, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Stochastic %K is 22.417, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Stochastic %D is 22.170, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) CCI_20 is -121.017, creating a Buy signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Awesome Oscillator (AO) is -0.477, creating a Sell signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Momentum (MOM) is -0.615, creating a Sell signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Average Convergence Divergence (MACD) is -0.249, creating a Sell signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 7.921 | Buy |
| MA_10 | 8.093 | Sell |
| MA_20 | 8.192 | Sell |
| MA_60 | 8.965 | Sell |
| MA_200 | 8.719 | Sell |
| MA_250 | 8.437 | Sell |
BioCryst Pharmaceuticals, Inc. (BCRX) 5-Day simple moving average is 7.921, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 10-Day simple moving average is 8.093, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 20-Day simple moving average is 8.192, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 60-Day simple moving average is 8.965, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 200-Day simple moving average is 8.719, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
BioCryst Pharmaceuticals, Inc. (BCRX) 250-Day simple moving average is 8.437, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.